Natashia Harasym
- Biomaterials top 2%
- Molecular Biology
- Biomedical Engineering top 10%
- Oncology
- Hematology top 5%
- Co-authors
- Lawrence D. MayerPaul TardiSharon A. JohnstoneTroy O. HarasymMarcel B. BallyPierrot HarvieDavid BermudesSherwin Xie
- Topics
- Nanoparticle-Based Drug Delivery (9 papers)Cancer therapeutics and mechanisms (4 papers)Microtubule and mitosis dynamics (4 papers)
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
Natashia Harasym
14 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 80
- Biomaterials 610
- Molecular Biology 564
- Biomedical Engineering 329
- Oncology 213
- Hematology 174
Countries citing papers authored by Natashia Harasym
This map shows the geographic impact of Natashia Harasym's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natashia Harasym with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natashia Harasym more than expected).
Fields of papers citing papers by Natashia Harasym
This network shows the impact of papers produced by Natashia Harasym. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natashia Harasym. The network helps show where Natashia Harasym may publish in the future.
Co-authorship network of co-authors of Natashia Harasym
This figure shows the co-authorship network connecting the top 25 collaborators of Natashia Harasym. A scholar is included among the top collaborators of Natashia Harasym based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natashia Harasym. Natashia Harasym is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 26 | |
| 3 | 77 | |
| 4 | Development of highly efficacious hydrophobic paclitaxel prodrugs delivered in nanoparticles for fixed-ratio drug combination applications | 3 |
| 5 | 288 | |
| 6 | 110 | |
| 7 | 29 | |
| 8 | 110 | |
| 9 | 276 | |
| 10 | 66 | |
| 11 | Synergistic antitumor activity observed for a fixed ratio liposome formulation of Cytarabine (Cyt):Daunorubicin (Daun) against preclinical leukemia models | 3 |
| 12 | A pharmaceutical approach to achieve synergy in vivo: A fixed ratio formulation of Irinotecan and Floxuridine for treatment of colorectal cancer | 2 |
| 13 | 70 | |
| 14 | 1 |
About Natashia Harasym
Natashia Harasym is a scholar working on Biomaterials, Pharmaceutical Science and Oncology, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Cancer therapeutics and mechanisms (4 papers) and Microtubule and mitosis dynamics (4 papers). The work is most often cited by research in Biomaterials (610 citations), Hematology (174 citations) and Pharmaceutical Science (91 citations). Natashia Harasym has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Lawrence D. Mayer, Paul Tardi, Sharon A. Johnstone, Troy O. Harasym, Marcel B. Bally, Pierrot Harvie, David Bermudes, Sherwin Xie, Euan C. Ramsay and Natalia Zisman. Their work appears in journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.